project update - October 6, 2025
FLAVIVACCINE Consortium held General Assembly to review project’s progress and next steps
The FLAVIVACCINE consortium held its General Assembly online on September 30 and October 2, bringing together partners from across Europe and the U.S. to reflect on recent progress and plan the next steps in the project.
During the two-day meeting, the consortium shared scientific updates and discussed strategies and approaches to further advance the development of the pan-flavivirus vaccine candidate.
FLAVIVACCINE partners during the online General Assembly
Following the scientific discussions, partners aligned on project management, regulatory pathways, and communication activities, ensuring coordinated progress across all areas.
After this General Assembly, the consortium has a clear strategy for the coming months, focusing on refining experimental approaches.
